BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 18333287)

  • 1. Progression of Kaposi sarcoma associated with iatrogenic Cushing syndrome in a person with HIV/AIDS.
    Jinno S; Goshima C
    AIDS Read; 2008 Feb; 18(2):100-4. PubMed ID: 18333287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iatrogenic Cushing's syndrome in an HIV-infected patient treated with inhaled corticosteroids (fluticasone propionate) and low dose ritonavir enhanced PI containing regimen.
    Clevenbergh P; Corcostegui M; Gérard D; Hieronimus S; Mondain V; Chichmanian RM; Sadoul JL; Dellamonica P
    J Infect; 2002 Apr; 44(3):194-5. PubMed ID: 12099750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ritonavir-fluticasone interaction causing Cushing syndrome in HIV-infected children and adolescents.
    Arrington-Sanders R; Hutton N; Siberry GK
    Pediatr Infect Dis J; 2006 Nov; 25(11):1044-8. PubMed ID: 17072128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iatrogenic Cushing's syndrome in HIV-infected patients receiving ritonavir and inhaled fluticasone: description of 4 new cases and review of the literature.
    Valin N; De Castro N; Garrait V; Bergeron A; Bouche C; Molina JM
    J Int Assoc Physicians AIDS Care (Chic); 2009; 8(2):113-21. PubMed ID: 19270151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenal suppression and Cushing's syndrome secondary to an interaction between ritonavir and fluticasone: a review of the literature.
    Foisy MM; Yakiwchuk EM; Chiu I; Singh AE
    HIV Med; 2008 Jul; 9(6):389-96. PubMed ID: 18459946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cushing syndrome and severe adrenal suppression caused by fluticasone and protease inhibitor combination in an HIV-infected adolescent.
    St Germain RM; Yigit S; Wells L; Girotto JE; Salazar JC
    AIDS Patient Care STDS; 2007 Jun; 21(6):373-7. PubMed ID: 17594245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cushing syndrome with secondary adrenal insufficiency from concomitant therapy with ritonavir and fluticasone.
    Johnson SR; Marion AA; Vrchoticky T; Emmanuel PJ; Lujan-Zilbermann J
    J Pediatr; 2006 Mar; 148(3):386-8. PubMed ID: 16615973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fluticasone-ritonavir: a drug-drug interaction causing iatrogenic Cushing's syndrome and adrenal insufficiency].
    Rousseau C; Dolz M
    Med Mal Infect; 2014 Oct; 44(10):483-4. PubMed ID: 25282607
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinically significant adverse events from a drug interaction between quetiapine and atazanavir-ritonavir in two patients.
    Pollack TM; McCoy C; Stead W
    Pharmacotherapy; 2009 Nov; 29(11):1386-91. PubMed ID: 19857154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iatrogenic Cushing's syndrome in a adolescent with AIDSs on ritonavir and inhaled fluticasone. Case report and literature review.
    Pessanha TM; Campos JM; Barros AC; Pone MV; Garrido JR; Pone SM
    AIDS; 2007 Feb; 21(4):529-32. PubMed ID: 17301576
    [No Abstract]   [Full Text] [Related]  

  • 11. Exogenous cushing syndrome mimicking human immunodeficiency virus lipodystrophy.
    Gupta SK; Dubé MP
    Clin Infect Dis; 2002 Sep; 35(6):E69-71. PubMed ID: 12203188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ritonavir and fluticasone: beware of this potentially fatal combination.
    Li AM
    J Pediatr; 2006 Mar; 148(3):294-5. PubMed ID: 16615953
    [No Abstract]   [Full Text] [Related]  

  • 13. [Iatrogenic Cushing syndrome in an HIV-infected female patient: be careful about interaction inhaled corticosteroids-ritonavir!].
    Bouldouyre MA; Moachon L; Guillevin L; Launay O
    Presse Med; 2008 Dec; 37(12):1834-5. PubMed ID: 18926662
    [No Abstract]   [Full Text] [Related]  

  • 14. Alopecia associated with ritonavir-boosted atazanavir therapy.
    Torres HA; Barnett BJ; Arduino RC
    AIDS; 2007 Jun; 21(10):1391-2. PubMed ID: 17545728
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhaled fluticasone causes iatrogenic cushing's syndrome in patients treated with Ritonavir.
    Mahlab-Guri K; Asher I; Gradstein S; Zung A; Radian-Sade S; Elbirt D; Sthoeger Z
    J Asthma; 2011 Oct; 48(8):860-3. PubMed ID: 21854345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Exogenous Cushing's syndrome as a serious side-effect of therapy with ritonavir an inhaled fluticasone].
    Machala L; Kréze A; Jilich D; Rozsypal H
    Klin Mikrobiol Infekc Lek; 2011 Jun; 17(3):103-5. PubMed ID: 21780031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ritonavir-boosted atazanavir, methadone, and ventricular tachycardia: 2 case reports.
    Gallagher DP; Kieran J; Sheehan G; Lambert J; Mahon N; Mallon PW
    Clin Infect Dis; 2008 Aug; 47(3):e36-8. PubMed ID: 18558878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exogenous Cushing syndrome with inhaled fluticasone in a child receiving lopinavir/ritonavir.
    Bhumbra NA; Sahloff EG; Oehrtman SJ; Horner JM
    Ann Pharmacother; 2007 Jul; 41(7):1306-9. PubMed ID: 17535841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cushing syndrome due to ritonavir-fluticasone interaction.
    Canalejo E; Pacheco MS
    CMAJ; 2012 Oct; 184(15):1714. PubMed ID: 22586335
    [No Abstract]   [Full Text] [Related]  

  • 20. [Iatrogenic Cushing's syndrome, diabetes mellitus and secondary adrenal failure in a human immunodeficiency virus patient treated with ritonavir boosted atazanavir and fluticasone].
    Collet-Gaudillat C; Roussin-Bretagne S; Desforges-Bullet V; Petit-Aubert G; Doll J; Beressi J-
    Ann Endocrinol (Paris); 2009 Sep; 70(4):252-5. PubMed ID: 19419710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.